Kintara Therapeutics, Inc. (KTRA) Stock Analysis
DELISTED 2024
What happened to Kintara Therapeutics, Inc. (KTRA) stock?
Kintara Therapeutics, Inc. (KTRA) no longer trades on public markets. It was delisted in October 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- October 2024
- Last recorded price (historical):
- $0.2154 (last quote on record before the October 2024 delisting; historical, not a current quote)
Market cap $12.0M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Kintara Therapeutics, Inc. (KTRA). Kintara Therapeutics, Inc. is a clinical-stage biotechnology firm focused on developing anti-cancer treatments. The company is advancing two key compounds, VAL-083 and REM-001, towards commercialization.
Last analyzed: Jun 15, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Kintara Therapeutics, Inc. (KTRA) Healthcare & Pipeline Overview
More about this archive record
Can I still buy KTRA shares?
No. KTRA stopped trading on public markets in October 2024, so the shares are not available through a broker. Anything you see quoted for KTRA elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before KTRA stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Kintara Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.